DR info

Clinical trials : 10 / Drugs : 7 - (DrugBank : 1) / Drug target genes : 16 - Drug target pathways : 7

Drugs and their primary sponsors and trial info

CCD 1042, MD 9150000, Mepalon 1042, SPT316
   Marinus Pharmaceuticals, Inc
      2019   Phase 3   EUCTR2018-004496-12-IT   Australia;Belgium;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom;United States;
   Marinus Pharmaceuticals, Inc.
      2019   Phase 3   EUCTR2018-004496-12-FR   Australia;France;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
      2015   -   EUCTR2015-001324-36-IT   Italy;United States;
      -   Phase 3   EUCTR2018-004496-12-DK   Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
CCD 1042, MD 9150000, Mepalon 1042, SPT3162
   Marinus Pharmaceuticals, Inc.
      2020   Phase 3   EUCTR2018-004496-12-HU   Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-004496-12-GB   Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004496-12-NL   Australia;Belgium;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
      -   Phase 2   EUCTR2018-004496-12-PL   Australia;Belgium;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
Ganaxolone
   Marinus Pharmaceuticals
      2019   Phase 2   NCT03865732   Australia;France;Hungary;Italy;Netherlands;Poland;United States;
      2015   Phase 2   NCT02358538   Italy;United States;
Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one)
   Marinus Pharmaceuticals, Inc.
      2015   -   EUCTR2015-001324-36-IT   Italy;United States;
Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one)
   Marinus Pharmaceuticals, Inc.
      2015   -   EUCTR2015-001324-36-IT   Italy;United States;